OR WAIT null SECS
November 26, 2021
Benchling raised $100 million to expand in Europe and further develop it's cloud-based R&D platform.
November 19, 2021
Novo Nordisk’s 3.3 billion acquisition of Dicerna gives them access to their RNAi technology.
Secarna Pharmaceuticals and Achilles Therapeutics have entered into an agreement to optimize the development of T cell therapies in Achilles’ pipeline.
CGT Catapult and Deep Science Ventures have partnered to encourage innovative approaches to overcoming barriers in delivering advance therapies to patients.
November 17, 2021
Kala’s acquisition of Combangio expands its clinical-stage biologic pipeline.
November 15, 2021
Under the expanded agreement with Agios, Centogene will provide global clinical trial support for thalassemia and sickle cell diseases.
November 12, 2021
AbbVie will pay REGENXBIO up to $1.75 billion for the rights to develop and commercialize its treatment of various eye conditions.
November 09, 2021
The agreement will allow Birmingham Biotech to commercialize the University of Birmingham’s antiviral COVID-19 nasal spray.
Element’s acquisition of JMI Laboratories will increase their North American service offerings.
November 03, 2021
Lonza is expanding its exosomes development and manufacturing capabilities with the acquisition of a service unit from Exosomics and a manufacturing facility from Codiak BioSciences.